Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension from weekly to every-other-week darbepoetin alfa in dialysis-dependent chronic kidney disease
2006-000074-79Phase 3Completed
- Sponsor
- Amgen
- Start
- Feb 2006
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of darbepoetin alfa in Uraemic Anaemia, sponsored by Amgen. Started Feb 2006; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on 2006-000074-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000074-79.